
SELECTIS HEALTH, INC.
100
Recent developments include strategic facility sales, leadership changes, and purchase and sale agreements for healthcare facilities in Georgia, reflecting active portfolio management and organizational updates.
- Selectis Health entered definitive purchase and sale agreements for Sparta and Warrenton transitional care facilities in Georgia, marking a strong organizational finish to 2025 [N6].
- The company made key leadership announcements in October 2024 and leadership appointments in December 2023, indicating ongoing management strengthening [N7][N8].
- In early 2026, Selectis Health completed the sale of two skilled nursing facilities in Georgia for $13.2 million, reducing its operated facilities to seven [S1].
Selectis Health, Inc. operates healthcare real estate and healthcare services through wholly-owned subsidiaries, focusing on senior housing and post-acute/skilled nursing facilities. The company shifted its business model in 2019 from leasing properties to third-party operators to owning and operating its facilities directly. Its portfolio includes assisted living, independent living, and skilled nursing facilities primarily located in the southern and southeastern United States. The company pursues a diversified investment strategy across property types, geographies, operators, and tenants to mitigate risk and enhance growth opportunities. Financing strategies emphasize conservative debt management with primarily fixed-rate obligations and multiple liquidity sources. Recent strategic transactions include the sale of two skilled nursing facilities in Georgia in early 2026. The company operates in a highly regulated environment subject to complex healthcare laws and reimbursement policies, which impact operational and financial performance. [S1][S2]
Selectis Health, Inc. is a healthcare real estate company that owns and operates assisted living, independent living, and skilled nursing facilities primarily in the southern and southeastern U.S. The company transitioned from leasing facilities to an owner-operator model starting in 2019. As of early 2026, it operates seven healthcare facilities following recent sales. Its investment strategy focuses on quality healthcare, opportunistic investing, portfolio diversification, and conservative financing. Financially, as of March 31, 2026, the company reported $1.29 million in cash and equivalents, a current ratio of 0.6, net income of $6.53 million for the quarter, and basic EPS of $2.13. The company faces competitive pressures and regulatory risks inherent in healthcare operations. Financial figures (if any) are summarized from the latest available SEC filings and are provided for informational purposes only — not financial advice. [S1][S2]
The company’s shift to an owner-operator model aligns revenue more closely with healthcare service provision, potentially enhancing profitability. Its diversified portfolio and opportunistic investment strategy may allow it to capitalize on favorable market conditions and healthcare industry growth trends. Conservative financing and multiple liquidity sources provide financial flexibility. Recent leadership appointments and strategic facility transactions indicate active portfolio management and organizational strengthening. [S1][N6][N7][N8]
Selectis Health faces risks from regulatory changes affecting reimbursement rates, particularly Medicaid and Medicare, which could impact profitability. The company’s current liquidity ratios indicate limited short-term asset coverage of liabilities, which may constrain operational flexibility. Competition from larger, better-capitalized investors may limit acquisition opportunities. Tenant and operator financial distress, including bankruptcy risk, could reduce rental and operational income. Exposure to litigation related to patient care, despite insurance coverage, presents potential financial and reputational risks. [S1][S2]
Selectis Health's moat derives from its integrated owner-operator model in healthcare real estate, combining property ownership with direct healthcare operations. This integration allows for greater control over quality of care and operational efficiencies. The company's diversified portfolio across senior housing and skilled nursing facilities, along with geographic and tenant diversification, reduces exposure to localized risks. Its established relationships with institutional lenders and conservative financing approach support financial stability. However, the company faces competition from larger REITs and institutional investors with potentially greater resources and lower capital costs. Regulatory compliance and maintaining high-quality care standards are critical to sustaining its competitive position. [S1]
• Regulatory and Reimbursement Risks: The company operates in a heavily regulated healthcare environment with complex federal, state, and local laws. Changes in reimbursement rates, especially from government programs like Medicare and Medicaid, could materially affect financial results.
• Tenant and Operator Financial Condition: Revenue depends on occupancy and the financial health of tenants and operators. Bankruptcy or insolvency of operators could disrupt income and increase costs.
• Liquidity and Financing Risks: Current liquidity ratios (current ratio 0.6, cash ratio 0.08 as of March 31, 2026) indicate limited short-term asset coverage of liabilities, which may affect the company’s ability to meet obligations and finance operations.
• Competitive Risks: The company faces competition from larger REITs, private equity, and institutional investors with potentially greater resources and lower capital costs, which may limit growth opportunities.
• Operational and Litigation Risks: The company is subject to claims of negligence related to patient care. While insurance coverage exists, exposure to litigation could result in material adverse financial impacts.
Business trends: Continued shift to owner-operator model in healthcare real estate, active portfolio management including facility sales and acquisitions, and focus on quality healthcare provision.
Execution milestones: Completion of facility sales in Georgia, leadership appointments, and maintenance of conservative financing structures.
Key risks: Regulatory reimbursement changes, tenant/operator financial health, liquidity constraints, competitive pressures, and operational litigation exposure.
Very high visibility
Visibility score reflects the breadth and consistency of available disclosure across SEC filings, recent public reporting, and baseline business context (research-only; not investment advice).
- Selectis Health, Inc. owns and operates assisted living, independent living, and skilled nursing facilities primarily in the southern and southeastern U.S. through wholly-owned subsidiaries [S1].
- The company transitioned from leasing long-term care facilities to third-party operators to an owner-operator model starting in 2019 [S1].
- Previously known as Global Healthcare REIT, Inc. until May 2021, and before that Global Casinos, Inc., the company rebranded to align with its healthcare operations [S1].
- Selectis Health's portfolio includes senior housing (independent and assisted living) and post-acute/skilled nursing facilities [S1].
- The company uses multiple investment approaches including direct property ownership, debt investments, developments/redevelopments, investment management, RIDEA structures, and owning healthcare operations [S1].
- Healthcare operations revenue has shifted from rental income to healthcare provision revenue, with operational teams focused on quality care standards aligned with CDC, ADA, CMS, and local guidelines [S1].
- The company owned 12 healthcare facilities as of December 31, 2025, operating 9 through subsidiaries, and after selling two facilities in January 2026, operates 7 facilities [S1].
- Selectis Health completed the sale of two skilled nursing facilities in Georgia in January 2026 for $13.2 million [S1].
- The company’s investment strategy emphasizes quality healthcare, opportunistic investing, portfolio diversification by type, geography, operator, tenant, and product, and conservative financing [S1].
- Financing includes managing debt-to-equity levels, maintaining liquidity, access to capital markets, and relationships with lenders and institutional partners; debt obligations are primarily fixed rate with staggered maturities [S1].
- Recent financing activities include renegotiations and extensions of senior secured notes and commercial lines of credit, with repayments completed in January 2026 [S1].
- As of March 31, 2026, Selectis Health reported cash and equivalents of $1.29 million, current assets of $9.82 million, current liabilities of $16.32 million, a current ratio of 0.6, and a cash ratio of 0.08 [S2].
- Net income for the quarter ended March 31, 2026 was $6.53 million, with basic EPS of $2.13 and diluted EPS of $1.90 [S2].
- The company faces competition from REITs, investment companies, private equity, hedge funds, sovereign funds, healthcare operators, lenders, developers, and other institutional investors [S1].
- Revenue depends on occupancy levels and the financial condition of tenants and operators; risks include tenant/operator bankruptcy or insolvency and regulatory changes affecting reimbursement rates [S1].
- Operations are subject to extensive federal, state, and local healthcare laws and regulations, including fraud and abuse laws, reimbursement rules, licensure, and quality reporting requirements [S1].
- The company maintains general and professional liability insurance to cover claims of negligence related to patient care, though exposure to such claims remains a risk [S1].
- Selectis Health has made key leadership appointments and completed strategic transactions including purchase and sale agreements for healthcare facilities in Georgia [N6][N7][N8].
- Recent news coverage includes the company’s definitive purchase and sale agreements for transitional care facilities in Georgia and leadership announcements [N6][N7][N8].
Generated 2026-05-22
- S1 | 2026-04-15 | 10-K
- S2 | 2026-05-22 | 10-Q
- N1 | 2026-05-22 | www.nasdaq.com | Stocks Climb on US-Iran Peace Hopes and Strength in Chipmakers | https://www.nasdaq.com/articles/stocks-climb-us-iran-peace-hopes-and-strength-chipmakers
- N2 | 2026-05-22 | www.nasdaq.com | Sugar Prices Slip on Stronger Sugar Exports from Thailand | https://www.nasdaq.com/articles/sugar-prices-slip-stronger-sugar-exports-thailand
- N3 | 2026-05-22 | www.nasdaq.com | Stocks Supported by US-Iran Peace Deal Optimism | https://www.nasdaq.com/articles/stocks-supported-us-iran-peace-deal-optimism
- N4 | 2026-05-22 | www.nasdaq.com | This Emerging Markets ETF Beat Its Benchmark by Nearly 10 Points. A Fund Recently Bought $31 Million | https://www.nasdaq.com/articles/emerging-markets-etf-beat-its-benchmark-nearly-10-points-fund-recently-bought-31-million
- N5 | 2026-05-22 | www.nasdaq.com | Q2 2026 Earnings Season Is Almost Over -- 3 Takeaways Investors Need To Know | https://www.nasdaq.com/articles/q2-2026-earnings-season-almost-over-3-takeaways-investors-need-know
- N6 | 2025-12-10 | www.nasdaq.com | Selectis Health Enters Definitive Purchase and Sale Agreement for Sparta and Warrenton Transitional Care Facilities in Georgia, capping a strong organizational finish to 2025 | https://www.nasdaq.com/press-release/selectis-health-enters-definitive-purchase-and-sale-agreement-sparta-and-warrenton
- N7 | 2024-10-17 | www.nasdaq.com | Selectis Health Makes Key Leadership Announcement | https://www.nasdaq.com/press-release/selectis-health-makes-key-leadership-announcement-2024-10-17
- N8 | 2024-05-09 | www.nasdaq.com | Selectis Health Enters Definitive Purchase and Sale Agreement for Archway Transitional Care Center in Georgia | https://www.nasdaq.com/press-release/selectis-health-enters-definitive-purchase-and-sale-agreement-for-archway
This material is for informational purposes only and does not constitute investment, financial, legal or tax advice, or an offer or solicitation to buy or sell any security. The Valye AI Score is a model-based estimate derived from public information and is subject to change without notice. No representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information herein. Past performance is not indicative of future results. Investors should conduct their own research and consult a qualified financial adviser before making any investment decisions.

Generated by Valye SEC Pipeline Engine
.gif)


